Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Corin Eyes Up Australia With New Ortho Acquisition

Executive Summary

Orthopedics firm Corin is targeting the competitive Australian market with its latest acquisition. The Cirencester, UK-based company announced a deal to acquire Global Orthopaedics Technology (GOT), a leading Australian orthopedics group.

You may also be interested in...



Patient-Specificity Meets Digital Ecosystems As Corin Acquires TKR Robotics Player Omni

Hip and knee replacement challenger firm Corin Group has a big ambition to revolutionize orthopedics with connected digital ecosystems and patient-specific concepts. That aim has come a step closer with its acquisition of robotic-assisted total knee replacement (TKR) company Omni Orthopaedics. Corin's Elvio Gramignano believes this approach will lead to real change in health care delivery.       

Patient-Specific Drive Takes Ortho Group Corin Into TKR Robotics With Omni Purchase

Hip and knee replacement firm Corin Group is taking its digitally-connected ecosystem concept a stage further after agreeing to acquire US-based Omni Orthopaedics Inc., a pioneer in robotic-assisted total knee replacement. The transaction will be completed in the first half of March.

Permira Inks Deal To Buy Orthopedics Firm Corin

Permira has signed a deal to acquire a majority stake in orthopedics group Corin from a group of investors for an undisclosed price.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123387

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel